BASEL, Switzerland,
March 24 /PRNewswire-FirstCall/ -
Neuro-Biotech Corp. (PINKSHEETS: MRES) (OTCQB: MRES) is pleased to
announce that effective immediately, the president of Credo-TM, Mr
Rustern Yusupov, will assume the position of Vice-President
Marketing. Mr Yusupov will be based out of Credo-TM`s head office
in Kazan, Russia. Mr Yusupov will
help lead the implementation of Neuro-Biotech licensees' network,
particularly in the creation of its own "Technological Showcase" to
support the training of technicians as well as the developments of
new products.
Mr. Yusupov has an extensive experience in
Internet and media advertising. Mr Yusupov is currently the Chief
Executive Officer of Credo-TM, a corporation that developed, with
the help of government grants, a solid distribution network of
advanced and modern medical products. Mr Yusupov`s company
currently employs more than 300 individuals. Over the years, Mr.
Yusupov has served on the boards of directors of private companies.
Mr Yusupov graduated in 1994 from the Kazan Aviation
University.
"I am excited to be joining a company that
develops products I believe in and have advocated for among my
distribution network. This is a great opportunity for me to
contribute to its continued strategic success." stated Yusupov.
For more information on Neuro-Biotech Corp or to
contact a company representative, please visit:
www.neuro-biotechcorp.com
FORWARD LOOKING STATEMENTS
This release contains statements that are made
pursuant to the Safe Harbor Provisions of the Private Securities
Litigation Act of 1995. Certain statements in this press release
may contain words such as "anticipates," "believes," "could,"
"expects," "intends," "may," "projects," "targets" and other
similar language that is considered forward-looking statements.
These forward-looking statements are subject to certain risks and
uncertainties and persons reading this release are cautioned that
such statements are only predictions, and that the Company's actual
future results or performance may be materially different. The
Company disclaims any intention or obligation to update or revise
forward-looking information, whether as a result of new
information, future events, or otherwise, could cause the company's
actual results to differ materially from those indicated in any
forward-looking statements.
SOURCE Neuro-Biotech Corp.